Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000477325) titled 'Population pharmacokinetics of isradipine in children with acute hypertension' on April 17.
Study Type: Observational
Study Design:
Duration: Longitudinal
Selection: Defined population
Timing: Prospective
Primary Sponsor: Child and Adolescent Health Service
Condition:
acute hypertension
acute hypertension
Cardiovascular - Hypertension
Intervention:
Participant will be receiving isradipine AS PART OF standard care (i.e. regardless of their involvement in this study). participant will be observed until post 8 hours of subsequent isradipine dose (can be either 2nd or 3rd dose).
dosage and duration given...